Last 47 quarters of trend data · Healthcare · Healthcare Software & Telehealth
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 35.77 | — | — | 11.79 | 128.13 | 41.87 | — | — | — | — | — | — | — | — | — | — | — | — | — | 452.70 | 9721.59 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +364.9% | — | |
| P/S Ratio | 1.67 | 1.31 | 1.48 | 1.84 | 3.74 | 2.20 | 1.82 | 0.69 | 1.66 | 2.43 | 2.80 | 2.23 | 1.98 | 4.39 | 4.81 | 3.82 | 4.42 | 8.88 | 12.27 | 13.91 | 24.14 |
| — | -40.4% | -18.6% | +166.1% | +125.3% | -9.4% | -34.9% | -68.9% | -16.2% | -44.8% | -41.7% | -41.8% | -55.1% | -50.5% | -60.8% | -72.5% | -81.7% | -56.8% | -29.8% | +79.8% | +226.9% | |
| P/B Ratio | 1.30 | 0.82 | 0.91 | 1.85 | 3.19 | 2.15 | 1.38 | 0.77 | 1.24 | 1.51 | 1.80 | 2.00 | 1.11 | 2.10 | 2.02 | 2.38 | 2.06 | 3.52 | 5.14 | 8.60 | 12.28 |
| — | -61.9% | -33.9% | +142.1% | +158.1% | +42.6% | -23.6% | -61.7% | +10.9% | -28.0% | -10.7% | -16.2% | -45.8% | -40.5% | -60.8% | -72.3% | -83.2% | -60.8% | -20.2% | -15.4% | +84.4% | |
| P/FCF | 8.95 | 3.13 | — | 8.39 | 30.54 | 14.10 | 10.42 | 286.90 | 20.81 | 65.49 | 28.09 | — | 28.11 | — | — | 27.00 | 19.45 | 441.19 | 41.98 | — | 10129.04 |
| — | -77.8% | — | -97.1% | +46.7% | -78.5% | -62.9% | — | -25.9% | — | — | — | +44.5% | — | — | — | -99.8% | -91.5% | -66.2% | — | — | |
| EV / EBITDA | 10.73 | 26.34 | 20.78 | 6.00 | 31.86 | 15.78 | — | 5.78 | — | — | — | — | — | — | — | — | — | — | — | 238.43 | 652.30 |
| — | +66.9% | — | +3.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +237.6% | +202.4% | |
| EV / EBIT | 13.86 | 829.34 | 59.38 | 6.90 | 45.28 | 20.29 | — | 7.25 | — | — | — | — | — | — | — | — | — | — | — | 421.02 | 9637.20 |
| — | +3987.8% | — | -4.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +395.7% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.3% | 76.5% | 69.9% | 74.8% | 67.2% | 63.8% | 60.9% | 68.1% | 63.1% | 62.2% | 62.0% | 62.9% | 60.0% | 56.6% | 57.2% | 63.4% | 62.4% | 64.3% | 59.0% | 61.0% | 56.3% |
| — | +19.9% | +14.8% | +9.7% | +6.5% | +2.6% | -1.8% | +8.4% | +5.2% | +9.9% | +8.4% | -0.8% | -3.9% | -11.9% | -3.1% | +3.9% | +10.9% | +8.9% | +8.2% | +16.5% | -1.5% | |
| Operating Margin | 11.0% | -0.4% | 2.0% | 27.7% | 7.9% | 10.9% | -9.6% | 11.2% | -40.2% | -19.9% | -25.5% | -38.4% | -21.8% | -35.1% | -54.3% | -4.4% | -24.9% | -28.0% | -27.4% | 3.1% | 0.2% |
| — | -103.9% | +120.7% | +146.5% | +119.6% | +154.8% | +62.3% | +129.3% | -84.7% | +43.2% | +53.0% | -773.9% | +12.6% | -25.5% | -98.3% | -243.8% | -10616.5% | -1220.1% | -381.9% | -63.0% | +114.1% | |
| Net Margin | 4.7% | -3.4% | -2.5% | 15.6% | 3.0% | 5.2% | -10.0% | -0.2% | -42.8% | -21.3% | -35.0% | -14.6% | -17.5% | -30.1% | -49.2% | -1.7% | -23.0% | -27.8% | -27.4% | 3.1% | 0.2% |
| — | -165.3% | +75.1% | +6550.4% | +107.0% | +124.6% | +71.4% | +98.3% | -144.1% | +29.2% | +28.8% | -780.6% | +23.7% | -8.4% | -79.6% | -154.0% | -9389.0% | -1175.4% | -382.6% | -62.9% | +109.2% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 4.2% | -0.5% | -0.4% | 4.0% | 0.6% | 1.3% | -1.9% | -0.1% | -7.7% | -3.3% | -5.5% | -3.4% | -2.5% | -3.5% | -5.1% | -0.3% | -2.6% | -2.9% | -2.9% | 0.5% | 0.0% |
| — | -141.5% | +79.6% | +6045.3% | +108.3% | +139.5% | +66.0% | +98.0% | -213.6% | +5.2% | -8.3% | -1239.1% | +3.7% | -21.4% | -78.5% | -152.8% | -8189.3% | -1100.3% | -286.3% | -82.8% | +105.1% | |
| ROA | 2.9% | -0.4% | -0.3% | 2.9% | 0.5% | 0.9% | -1.3% | -0.0% | -5.4% | -2.3% | -3.8% | -2.7% | -2.3% | -3.3% | -4.8% | -0.2% | -2.4% | -2.7% | -2.7% | 0.5% | 0.0% |
| — | -146.6% | +77.8% | +6331.5% | +108.5% | +139.6% | +66.2% | +98.3% | -131.0% | +30.2% | +20.2% | -1018.8% | +4.5% | -20.9% | -78.3% | -153.2% | -8257.3% | -1101.3% | -297.2% | -80.8% | +105.9% | |
| ROIC | 6.8% | -0.1% | 0.2% | 5.1% | 1.2% | 1.8% | -1.2% | 2.0% | -4.6% | -2.0% | -2.6% | -6.4% | -2.5% | -3.4% | -4.9% | -0.7% | -4.0% | -6.1% | -6.3% | 1.0% | 0.1% |
| — | -102.8% | +119.1% | +153.9% | +125.1% | +192.1% | +54.2% | +131.5% | -85.3% | +42.2% | +47.6% | -869.4% | +36.7% | +44.2% | +22.2% | -163.1% | -5860.0% | -1070.1% | -426.4% | -61.5% | +116.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.20 | 0.15 | 0.18 | 0.20 | 0.23 | 0.24 | 0.28 | 0.28 | 0.31 | 0.30 | 0.30 | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | -38.8% | -35.1% | -28.3% | -25.0% | -18.5% | -5.2% | -2.5% | +24276.3% | +236560.3% | +17259.4% | +15552.3% | -34.8% | -93.6% | -25.3% | -25.5% | -31.2% | -37.5% | -34.2% | -72.2% | -72.2% | |
| Debt / EBITDA | 1.59 | 19.96 | 16.24 | 2.61 | 9.14 | 6.80 | — | 7.02 | — | — | — | — | — | — | — | — | — | — | — | 0.30 | 0.64 |
| — | +193.7% | — | -62.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +17.4% | -53.5% | |
| Current Ratio | 3.04 | 5.58 | 5.37 | 3.04 | 3.05 | 2.57 | 2.82 | 2.89 | 3.23 | 3.07 | 2.88 | 3.04 | 11.35 | 15.44 | 12.61 | 11.74 | 16.19 | 17.14 | 16.39 | 12.29 | 14.31 |
| — | +117.1% | +90.6% | +5.2% | -5.7% | -16.4% | -2.3% | -4.8% | -71.5% | -80.1% | -77.1% | -74.1% | -29.9% | -9.9% | -23.1% | -4.4% | +13.2% | +8.8% | -11.5% | +275.0% | +326.2% | |
| Quick Ratio | 3.04 | 5.58 | 5.37 | 3.04 | 3.05 | 2.57 | 2.82 | 2.89 | 3.23 | 3.07 | 2.88 | 3.04 | 11.35 | 15.44 | 12.61 | 11.74 | 16.19 | 17.14 | 16.39 | 12.29 | 14.31 |
| — | +117.1% | +90.6% | +5.2% | -5.7% | -16.4% | -2.3% | -4.8% | -71.5% | -80.1% | -77.1% | -74.1% | -29.9% | -9.9% | -23.1% | -4.4% | +13.2% | +8.8% | -11.5% | +275.0% | +326.2% | |
| Interest Coverage | 2.31 | 0.03 | 0.44 | 7.02 | 1.91 | 2.07 | -1.53 | 2.41 | -5.52 | -2.34 | -3.24 | -5.65 | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying OPRX stock.
OptimizeRx Corp.'s current P/E is 35.8x. The average P/E over the last 2 quarters is 70.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
OptimizeRx Corp.'s current operating margin is 11.0%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking OptimizeRx Corp.'s business trajectory between earnings reports.